SCUBE3

SCUBE3 is a secreted, proteolytically processed glycoprotein that functions as a versatile co-receptor for multiple growth factor signaling pathways, modulating TGF-β, BMP, FGF, and EGFR signaling to control cell proliferation, differentiation, and tissue morphogenesis. Its C-terminal CUB domain directly binds TGF-β type II receptor (TGFβRII) and TGF-β1, activating Smad2/3 phosphorylation and epithelial–mesenchymal transition, while also engaging BMP2/BMP4 and recruiting BMP receptor complexes into lipid raft microdomains to enhance BMP-mediated chondrogenesis, osteogenesis, and odontoblastic differentiation (PMID:21441952, PMID:33308444, PMID:37189178). SCUBE3 additionally augments FGF8 signaling as a co-receptor during fast muscle differentiation and interacts with EGFR and mutant CALR to activate FOXR2/c-Myc–driven oncogenic transcription and DNMT1-mediated MHC class I/II suppression (PMID:24849601, PMID:41329749). Loss-of-function variants in SCUBE3 cause craniofacial, dental, and skeletal growth defects in humans and mice through impaired BMP signaling (PMID:33308444).

1. 2007 Medium

   Establishing that SCUBE3 physically engages TGF-β1 and enhances TGF-β transcriptional activity revealed it as a secreted modulator of TGF-β signaling, with in vivo cardiac hypertrophy in overexpressing mice demonstrating physiological relevance.

   Evidence Co-IP/pulldown with TGF-β1, transgenic mouse model with echocardiography

   PMID:17442284

   Open questions at the time

   • Specific receptor involved (TGFβRII) not yet identified
   • Mechanism of TGF-β pathway enhancement unresolved
   • Single lab without independent replication
2. 2011 High

   Identification of TGFβRII as the direct receptor partner for the SCUBE3 CUB domain, together with demonstration that MMP-2/9-mediated cleavage releases functional fragments, established the molecular basis by which secreted SCUBE3 activates Smad2/3 signaling and EMT.

   Evidence Domain-specific pulldown/binding assay, Smad2/3 phosphorylation, SCUBE3 knockdown and overexpression, in vivo xenograft in lung cancer cells

   PMID:21441952

   Open questions at the time

   • Whether cleaved EGF-like repeats have independent signaling functions
   • Structural details of CUB–TGFβRII interaction unknown
3. 2014 High

   Genetic epistasis in zebrafish showed that SCUBE3 functions as an FGF co-receptor augmenting FGF8 signaling, broadening its role beyond TGF-β to include FGF-dependent developmental programs in fast muscle differentiation.

   Evidence Morpholino knockdown in zebrafish, epistasis with fgf8 mutants, C2C12 myoblast knockdown, immunofluorescence

   PMID:24849601

   Open questions at the time

   • Direct biochemical binding between SCUBE3 and FGF8 or FGFR not demonstrated
   • Whether this co-receptor function operates in mammals
4. 2020 High

   Demonstration that SCUBE3 recruits BMP receptor complexes into lipid raft microdomains and that human loss-of-function variants and Scube3-knockout mice exhibit craniofacial and skeletal defects established SCUBE3 as a BMP2/BMP4 co-receptor essential for bone and tooth development, linking it to a Mendelian skeletal phenotype.

   Evidence Co-receptor binding assays, lipid raft fractionation, Scube3 knockout mouse, human variant functional validation

   PMID:33308444

   Open questions at the time

   • Crystal structure of SCUBE3–BMP–BMPR complex unavailable
   • Relative contributions of BMP vs TGF-β co-receptor functions in specific tissues unclear
5. 2022 Medium

   Discovery that DEPDC1B stabilizes SCUBE3 protein by competitively sequestering the ubiquitin ligase CDC16 revealed a post-translational regulatory axis controlling SCUBE3 abundance and downstream angiogenic output.

   Evidence Co-IP, ubiquitin-proteasome degradation assays, gain/loss-of-function, in vivo angiogenesis in melanoma

   PMID:35088579

   Open questions at the time

   • Whether CDC16-mediated ubiquitination is direct or via APC/C complex unclear
   • Regulation of SCUBE3 stability in non-cancer contexts unknown
   • Single lab
6. 2023 Medium

   ChIP and reporter assays identifying SCUBE3 as a direct β-catenin/TCF4 transcriptional target placed SCUBE3 downstream of Wnt signaling, while its paracrine role in promoting dental pulp stem cell differentiation via both TGF-β and BMP2 illustrated dual pathway engagement in tissue regeneration.

   Evidence ChIP for TCF4 binding at SCUBE3 promoter, luciferase reporter, co-culture with dental pulp stem cells, inhibitor studies, organoid model

   PMID:37189178 PMID:38109990

   Open questions at the time

   • Whether Wnt-driven SCUBE3 expression is a general mechanism across tissues
   • Quantitative contribution of autocrine vs paracrine SCUBE3 signaling unresolved
7. 2024 Medium

   Interaction studies showing SCUBE3 binds EGFR, mutant CALR, and TGFβRI/II, coupled with genomic screening revealing FOXR2/c-Myc activation and DNMT1-mediated MHC suppression, expanded the co-receptor repertoire of SCUBE3 to include EGFR and defined a mechanism for tumor immune evasion.

   Evidence Loss-of-function genomic screen, protein interaction studies, neutralizing antibody, patient-derived xenografts across multiple cancer models

   PMID:41329749

   Open questions at the time

   • Whether SCUBE3–EGFR interaction is direct or bridged by CALR
   • Structural basis for multi-receptor engagement unknown
   • Single study, awaits independent confirmation

• The structural basis for how a single secreted protein simultaneously engages TGFβRII, BMPRs, FGFRs, and EGFR — and whether tissue-specific proteolytic processing or post-translational modifications dictate receptor selectivity — remains unresolved.
• No high-resolution structure of SCUBE3 or its receptor complexes
• Domain-specific contributions to each receptor interaction not systematically mapped
• In vivo conditional knockouts in adult tissues lacking